Scientists investigate key immune cells in severe drug allergy

NCT ID NCT04330118

Recruiting now Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to understand how a type of white blood cell called eosinophils contributes to DRESS syndrome, a severe and potentially life-threatening drug allergy. Researchers will compare blood and skin samples from 80 adults with DRESS, other drug rashes, and healthy volunteers. The goal is to find better ways to diagnose and treat this condition in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRESS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic disease drug allergy drug rash with eosinophilia and systemic symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRESS SYNDROME DRUG HYPERSENSITIVITY

Contacts and locations

Locations

Assistance Publique - Hôpitaux de Paris - HENRI MONDOR
RECRUITING

Créteil, France
CH LENS
RECRUITING

Lens, France
CH d'Arras
RECRUITING

Arras, France
CH de Boulogne
RECRUITING

Boulogne-sur-Mer, France
CH de Douai
RECRUITING

Douai, France
CH de Dunkerque
RECRUITING

Dunkirk, France
CH de Roubaix
RECRUITING

Roubaix, France
CH de Valenciennes
RECRUITING

Valenciennes, France
Groupe Hospitalier de l'Institut Catholique de Lille
RECRUITING

Lille, France
Hop Claude Huriez Chr Lille
RECRUITING

Lille, 59000, France
Hôpital FOCH
RECRUITING

Suresnes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.